Connect with us

Headlines of The Day

Aster DM Q4FY24: Occupancy dips QoQ; bed expansion to drive growth

Aster DM Healthcare has reiterated margin target of 20% at the consol level for the next 3 years. The company is looking for M&A opportunities, especially in Maharashtra and UP.

Prabhudas Lilladher has maintained a `Buy’ rating with a TP of Rs400, valuing the India hospital segment at 23x EV/EBITDA on FY26E EBITDA. Utilization of proceeds and timely expansion will be key monitorable in the near term.

For full Q4FY24 result update, click. Prabhudas Lilladher

Copyright © 2024 Medical Buyer

error: Content is protected !!